Key Insights

Highlights

Success Rate

82% trial completion

Published Results

61 trials with published results (22%)

Research Maturity

168 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.7%

38 terminated out of 278 trials

Success Rate

81.6%

-5.0% vs benchmark

Late-Stage Pipeline

20%

56 trials in Phase 3/4

Results Transparency

36%

61 of 168 completed with results

Key Signals

61 with results82% success38 terminated

Data Visualizations

Phase Distribution

212Total

Not Applicable (45)

Early P 1 (2)

P 1 (51)

P 2 (58)

P 3 (44)

P 4 (12)

Trial Status

Completed168

Terminated38

Unknown34

Recruiting20

Withdrawn8

Active Not Recruiting5

Trial Success Rate

81.6%

Benchmark: 86.5%

Based on 168 completed trials

Clinical Trials (278)

Showing 20 of 20 trials

NCT07367282Phase 4RecruitingPrimary

Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration

NCT07496567Phase 2RecruitingPrimary

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

NCT07440225Phase 2RecruitingPrimary

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

NCT06779773Recruiting

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

NCT07216924Not ApplicableNot Yet RecruitingPrimary

Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss

NCT06635148Phase 2Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

NCT03011541Not ApplicableRecruiting

Stem Cell Ophthalmology Treatment Study II

NCT04658251Terminated

Study of New Mutations in Cone Disorders

NCT07577219Not ApplicableRecruiting

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

NCT04567303Phase 1Active Not RecruitingPrimary

Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

NCT02827071Terminated

Ocular Imaging Study Using Advanced OCT

NCT05637255Phase 2Completed

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

NCT07497815Not Yet RecruitingPrimary

Artificial Intelligence-assisted Diagnosis in Ophthalmology

NCT05439759Not ApplicableActive Not Recruiting

Factors in Learning And Plasticity: Healthy Vision

NCT05454124Not ApplicableRecruiting

Factors in Learning And Plasticity: Macular Degeneration

NCT04008121Early Phase 1Recruiting

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

NCT03846193Phase 1Terminated

FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

NCT04762368Not ApplicableRecruitingPrimary

Learning Study: Improving Vision in Adults With Macular Degeneration